about
The emerging role of oxylipins in thrombosis and diabetesLipidomic profiling of bioactive lipids by mass spectrometry during microbial infectionsExported Epoxide Hydrolases Modulate Erythrocyte Vasoactive Lipids during Plasmodium falciparum InfectionThe role of long chain fatty acids and their epoxide metabolites in nociceptive signalingComparison of free serum oxylipin concentrations in hyper- vs. normolipidemic menOmeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain modelAnti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal UlcersOral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin patternInducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease?Mice deficient in intestinal epithelium cytochrome P450 reductase are prone to acute toxin-induced mucosal damage.Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells.Intimal smooth muscle cells are a source but not a sensor of anti-inflammatory CYP450 derived oxylipins.Roles of the epoxygenase CYP2J2 in the endothelium.Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammationMetabolomics profiling of the free and total oxidised lipids in urine by LC-MS/MS: application in patients with rheumatoid arthritisHuman inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment.Soluble Epoxide Hydrolase Inhibition and Epoxyeicosatrienoic Acid Treatment Improve Vascularization of Engineered Skin SubstitutesPseudomonas aeruginosa sabotages the generation of host proresolving lipid mediatorsEffect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.Endothelial Nox4-based NADPH oxidase regulates atherosclerosis via soluble epoxide hydrolase.Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation.Anti-inflammatory ω-3 endocannabinoid epoxides.Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries.Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells.Orally Active Epoxyeicosatrienoic Acid Analogs.Inhibition of Soluble Epoxide Hydrolase 2 Ameliorates Diabetic Keratopathy and Impaired Wound Healing in Mouse Corneas.Identification of Discriminating Metabolic Pathways and Metabolites in Human PBMCs Stimulated by Various Pathogenic Agents.
P2860
Q26823893-69C4F317-6BB3-45B2-8C16-A7EAC52C9EC7Q26825122-5D2ED60A-41F8-4F29-ADFE-83DF972E3AFBQ27974556-A779CB66-692C-4537-BEE8-B3A830A7D1D3Q28248377-A5E56168-990F-4BC6-9EBF-C0AE798A1CC5Q28387829-6B6E39A6-A96C-4E69-8BB6-0476C2EC17DCQ28395323-FCB36917-58DB-407E-84B9-B05BDE4AE27BQ28395478-622DD260-790B-42D7-B44D-BCA4D270F90AQ28397238-21D913D3-18AC-493E-BD81-9F07602EDCA8Q28533445-44F84DF1-1F3D-4166-A943-8496ABF9721FQ33840727-C249AB61-5A59-4900-9011-EA1B1254B17BQ34774458-D7F8C254-9504-44AC-BB4A-92CDBBF178DFQ35649907-C3F4B55E-F14B-4287-87D0-2FACC61123AAQ35944656-AF31E064-D5D7-4E5A-8DD1-4D6A0C83F664Q37014713-79487BD4-F58B-406B-8BC1-167C78FF52CDQ37120799-2C77C6B3-CF97-4297-BD6F-8D00690C16A7Q37227519-D144E4AE-AE00-46A6-9A85-0810F318498AQ37440655-1EDF2401-31BB-4566-B46D-1D48A1D39A8FQ37574562-9FDE9BBB-9E14-4094-9388-605AD8F9134FQ37577177-C54D069D-2721-4F71-B493-5623A36B321BQ39431317-F352D37C-E1B3-409F-BA46-D368E4359EC0Q39644067-26920C34-8F88-4BDA-8281-1D8351140F94Q45976996-02A58205-9652-4990-9F67-F325F9F8F2ACQ46049422-A01287E4-DE4D-42F3-AB0A-F38A2ECEA72AQ46249034-42F2DA49-C1F7-458B-80DE-8E1732477DD2Q47192779-0C487BCB-2262-49A8-A742-62A29A65C547Q47948005-9F937676-94B4-40A0-89F5-8D9F9352B8B7Q48113987-1C713378-ADB9-400F-8EF8-7EDCB5BC1FF2Q49893120-930F2232-7649-4374-ADDA-D5B9AAE41363Q49929536-3BE216E5-E66A-4881-BD5A-F390F7AB0B05Q52609150-14527885-515F-4038-9499-77000AD70840Q55052744-C16CF205-E1E3-4017-800D-8AC25172A69B
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Anti-inflammatory effects of epoxyeicosatrienoic acids
@ast
Anti-inflammatory effects of epoxyeicosatrienoic acids
@en
Anti-inflammatory effects of epoxyeicosatrienoic acids
@nl
type
label
Anti-inflammatory effects of epoxyeicosatrienoic acids
@ast
Anti-inflammatory effects of epoxyeicosatrienoic acids
@en
Anti-inflammatory effects of epoxyeicosatrienoic acids
@nl
prefLabel
Anti-inflammatory effects of epoxyeicosatrienoic acids
@ast
Anti-inflammatory effects of epoxyeicosatrienoic acids
@en
Anti-inflammatory effects of epoxyeicosatrienoic acids
@nl
P2093
P2860
P3181
P356
P1476
Anti-inflammatory effects of epoxyeicosatrienoic acids
@en
P2093
Ara Askari
David Bishop-Bailey
Scott J Thomson
P2860
P304
P3181
P356
10.1155/2012/605101
P407
P577
2012-01-01T00:00:00Z